Differential activation of the ER stress factor XBP1 by oligomeric assemblies

Neurochemical Research

Volumn 37, Issue 8, 2012, Pages 1707-1717

  Castillo Carranza, Diana L ^a   Zhang, Yan ^b   Guerrero Muñoz, Marcos J ^a   Kayed, Rakez ^a   Rincon Limas, Diego E ^b   Fernandez Funez, Pedro ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Amyloids; ER stress; Neurodegeneration; Oligomers; XBP1

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MONOMER; OLIGOMER; PRION PROTEIN; X BOX BINDING PROTEIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DENATURATION; ELECTROPHORESIS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; HUMAN; HUMAN CELL; INTRON; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; XBP1 GENE;

ALPHA-SYNUCLEIN; BASE SEQUENCE; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM STRESS; HUMANS; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; PRIONS; PROTEIN MULTIMERIZATION; PROTEOSTASIS DEFICIENCIES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84864347798     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0780-7     Document Type: Article

References (38)

1. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD (2007) XBP1 controls diverse cell type-and condition-specific transcriptional regulatory networks. Mol Cell 27:53-66
2. Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3:11-40
3. Arispe N, Rojas E, Pollard HB (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A 90:567-571
4. Bartels T, Choi JG, Selkoe DJ (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107-110
5. Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15:349-357
6. Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas DE, Fernandez-Funez P (2011) The ER stress factor XBP1 s prevents amyloid-beta neurotoxicity. Hum Mol Genet 20:2144-2160
7. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298
8. Chang RC, Wong AK, Ng HK, Hugon J (2002) Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease, NeuroReport 13:2429-2432
9. Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect Biol 3:a006833
10. Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM (1022) Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 2004: 164-172
11. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294-17300
12. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283:29639-29643
13. Glabe CG, Kayed R (2006) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66:S74-S78
14. Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson's syndromes: a critical review. Curr Opin Genet Dev 19:254-265
15. Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89-102
16. Hetz C, Lee AH, Gonzalez-Romero D, Thielen P, Castilla J, Soto C, Glimcher LH (2008) Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A 105:757-762
17. Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W (2007) Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 354:707-711
18. Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, Scheper W (2005) The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol (Berl) 110:165-172
19. Hu X, Crick SL, Bu G, Frieden C, Pappu RV, Lee JM (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A 106:20324-20329
20. Ilieva EV, Ayala V, Jove M, Dalfo E, Cacabelos D, Povedano M, Bellmunt MJ, Ferrer I, Pamplona R, Portero-Otin M (2007) Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130:3111-3123
21. Kayed R, Glabe CG (2006) Conformation-dependent antiamyloid oligomer antibodies. Methods Enzymol 413:326-344
22. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489
23. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448-6453
24. Lee JH, Won SM, Suh J, Son SJ, Moon GJ, Park UJ, Gwag BJ (2010) Induction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 mice. Exp Mol Med 42:386-394
25. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373:2055-2066
26. Masek T, Vopalensky V, Suchomelova P, Pospisek M (2005) Denaturing RNA electrophoresis in TAE agarose gels. Anal Biochem 336:46-50
27. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866
28. Paschen W, Mengesdorf T (2005) Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38:409-415
29. Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T, Wada D, Kitagawa H, Watanabe TK (2009) Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res 1257:16-24
30. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
31. Singh N, Gu Y, Bose S, Kalepu S, Mishra RS, Verghese S (2002) Prion peptide 106-126 as a model for prion replication and neurotoxicity. Front Biosci 7:a60-a71
32. Terry RD (1996) The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55:1023-1025
33. Thies W, Bleiler L (2011) Alzheimer's disease facts and figures. Alzheimers Dement 7(2011):208-244
34. Truant R, Atwal RS, Desmond C, Munsie L, Tran T (2008) Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBS J 275:4252-4262
35. Tsachaki M, Ghiso J, Efthimiopoulos S (2008) BRI2 as a central protein involved in neurodegeneration. Biotechnol J 3:1548-1554
36. Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399:776-781
37. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44:181-193
38. Yoshida H (2007) ER stress and diseases. FEBS J 274:630-658